Live discussion: Amyloid-β degradation: The forgotten half of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 5, Issue 6, 2003, Pages 491-497

  Whitaker, Chastity ^a   Eckman, Chris ^b   Almeida, Claudia ^c   Feinstein, Douglas ^d   Atwood, Craig ^e   Eckman, Elizabeth ^b   Crutcher, Keith ^f   Hersh, Lou ^g   Leissring, Malcolm ^h   LaVoie, Matthew ^h   Ertekin Taner, Nilufer ^b   Shapiro, Paul ⁱ   Takahashi, Reisuke ^c   Yamin, Rina ^j   Mansourian, Stefan ^h   Estus, Steve ^g   Lesné, Sylvain ^k   Turner, Tony ^l   Farris, Wes ^h  

^a OHIO STATE UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

^c Cornell University ^*  (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ ELAN PHARMACEUTICALS   (United States)

^j BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITÉ DE CAEN   (France)

^l KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; INSULIN; MEMBRANE METALLOENDOPEPTIDASE; PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ALZHEIMER DISEASE; ANIMAL MODEL; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; IMMUNOCYTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; NOTE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 9144274938     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2003-5612     Document Type: Note

References (0)